News & Events
Press Releases
MAR 27, 2024
BUSINESSWIRE
KeifeRx Announces the Appointments of Dan Feehan and Alison Finger to Board of Directors
JAN 8, 2024
PR NEWSWIRE
KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for
Portfolio of Novel Tyrosine Kinase Inhibitors
FEB 14, 2023
PR NEWSWIRE
KeifeRx Appoints Garrett Vygantas, MD, MBA, to Board of Directors
DECEMBER 8, 2021
PR NEWSWIRE
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
JULY 20, 2021
PR NEWSWIRE
KeifeRx Receives FDA Acceptance of Investigational New Drug for Phase 3 Study of Nilotinib BE in Early Alzheimer’s Disease
MARCH 31, 2021
PR NEWSWIRE
KeifeRx Builds Leadership Team with Announcement of Chris Hoyt as Chief Executive Officer
MAY 29, 2020
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial Georgetown University Medical Center
OCTOBER 8, 2019
Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia Georgetown University
SEPTEMBER 27, 2018
Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown Georgetown University
JULY 16, 2017
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models Georgetown University
FEBRUARY 27, 2017
Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson’s Disease Georgetown University
SEPTEMBER 29, 2016
Georgetown receives FDA clearance to conduct clinical trial with nilotinib in Alzheimer’s disease Georgetown University
Media
JANUARY 1, 2024
LIFE SCIENCE LEADER
KeifeRx has a full range of neuroscience (NS) drug candidates in development, spanning later-stage clinical assets to several novel, pre-IND technologies
Jul 5, 2023
EMPOWERED PATIENT PODCAST
Using TKIs to Remove Toxic Proteins in the Brain with Chris Hoyt KeifeRx TRANSCRIPT
JANUARY 26, 2022
FOX BUSINESS
Keiferx CEO on new method for treating Alzheimer’s, neurodegenerative disease
JANUARY 19, 2022
THE BIO REPORT
Disposing Toxic Proteins to Treat Neurodegenerative Diseases
NOVEMBER 12, 2021
GENETIC ENGINEERING & BIOTECH NEWS
Parkinson’s Disease Trial Reveals Defects in Blood-Brain Barrier
NOVEMBER 12, 2021
GEORGETOWN MEDICAL CENTER
Vascular defects appear to underlie the progression of Parkinson’s disease
OCTOBER 20, 2020
MEDSCAPE MEDICAL NEWS
CML Drug Nilotinib Shows Early Effects in Alzheimer’s Disease
DECEMBER 16, 2019
JAMA NETWORK
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease – Audio
OCTOBER 22, 2019
SCIENCE DAILY
Novel agent flips on garbage disposal in neurons, eliminating toxic brain proteins in mice
JUNE 4, 2019
TRIALSITE NEWS
Could a Pfizer Cancer Drug be a Treatment for a Form of Dementia? Georgetown University Launches Clinical Trial to Find Out
MARCH 13, 2019
MEDSTAR HEALTH NEWS
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MARCH 17, 2017
THE SCIENCE TIMES
Leukemia Drug Nilotinib Can Cure Parkinson’s, Alzheimer’s & Dementia As Well
MARCH 15, 2017
NPR
Cancer Drug That Might Slow Parkinson’s, Alzheimer’s Headed For Bigger Tests
JANUARY 26, 2017
ALZHEIMER’S NEWS TODAY
Georgetown to Lead Phase 2 Study of Cancer Drug in Treating Alzheimer’s
OCTOBER 10, 2016
THE CONVERSATION
Nobel prize – winning autophagy research laid groundwork for potential Parkinson’s treatment
OCTOBER 3, 2016
LOS ANGELES TIMES
Japanese scientist Yoshinori Ohsumi wins Nobel Prize in medicine for work on cellular ‘recycling’
SEPTEMBER 29, 2016
GEORGETOWN UNIVERSITY
Georgetown receives FDA clearance to conduct clinical trial with nilotinib in Alzheimer’s disease
SEPTEMBER 29, 2016
ALZHEIMER’S DRUG DISCOVERY FOUNDATION
New Clinical Trial Will Test Cancer Drug as Alzheimer’s Treatment
AUGUST 10, 2016
THE GUARDIAN
New research hints at pattern of Alzheimer’s spread in the brain
AUGUST 1, 2016
THE PHARMA LETTER
AAIC 2016 showcases exciting Alzheimer’s developments
JULY 18, 2016
PARKINSON’S NEWS TODAY
Cancer drug raises dopamine levels, eases Parkinson’s symptoms in early study in patients
JULY 15, 2016
NEUROLOGYADVISOR
Leukemia drug may have benefits for Parkinson’s disease
JULY 14, 2016
DRUG DISCOVERY & DEVELOPMENT
Cancer drug could improve Parkinson’s symptoms
JULY 13, 2016
EUROPEAN PHARMACEUTICAL REVIEW
Collaboration to explore nilotinib as a potential treatment for Parkinson’s
JULY 13, 2016
FIERCEBIOTECH
Novartis cancer drug to be tested for Parkinson’s disease
JULY 11, 2016
BIOPHARMA DIVE
Cancer drug could benefit Parkinson’s patients, study shows
OCTOBER 20, 2015
NEW SCIENTIST
Drug reversed my Parkinson’s symptoms and let me read again
OCTOBER 19, 2015
HUFFINGTON POST
Parkinson’s drug trial branded ‘life-changing’ after helping patients walk and talk again
OCTOBER 19, 2015
FORTUNE
Parkinson’s patients show improvement after taking cancer drug
OCTOBER 19, 2015
EUROPEAN PHARMACEUTICAL REVIEW
Nilotinib improved cognition and motor skills in Parkinson’s trial
OCTOBER 19, 2015
AUDIO STORY
Local researchers working on groundbreaking treatment for Parkinson’s – Pt 2
OCTOBER 19, 2015 AUDIO STORY
Local researchers working on groundbreaking treatment for Parkinson’s – Pt 1
OCTOBER 19, 2015
DIGITAL JOURNAL
Cancer drug shows promise with reversing Parkinson’s disease
OCTOBER 19, 2015
HNGN
Cancer drug shows promise in reversing Parkinson’s and dementia
OCTOBER 19, 2015
MEDICAL NEWS TODAY
Man walks again as cancer drug is trialled for Parkinson’s
OCTOBER 19, 2015
WTOP ONLINE
Local researchers working on groundbreaking treatment for Parkinson’s
OCTOBER 19, 2015
NBC4
Cancer drug could be medical breakthrough for Parkinson’s disease patients
OCTOBER 19, 2015
POURQUOI DOCTEUR
Maladie de Parkinson : un anti-cancéreux produit des résultats inespérés
OCTOBER 19, 2015
PSYCHIATRY ADVISOR
Cancer drug improves Parkinson’s symptoms and progression
OCTOBER 18, 2015
MEDICAL XPRESS
Cancer drug improved cognition and motor skills in small Parkinson’s clinical trial
OCTOBER 18, 2015 CTV NEWS
Cancer drug shows promise for reversing symptoms of Parkinson’s disease
OCTOBER 18, 2015
THE INDEPENDENT
Parkinson’s patients ‘walk and talk again’ after receiving cancer drug in trial
OCTOBER 18, 2015
DAILY MAIL
Parkinson’s victims ‘brought back to life’: Cancer drug’s amazing effect echoes Awakenings film
OCTOBER 17, 2015
BLOOMBERG
Novartis cancer drug shows promise as treatment for Parkinson’s
OCTOBER 17, 2015
HEALTHLINE NEWS
Cancer drug offers new hope for Parkinson’s and Alzheimer’s diseases
OCTOBER 17, 2015
SCIENCE DAILY
Cancer drug improved cognition, motor skills in small Parkinson’s clinical trial
OCTOBER 17, 2015
GEORGETOWN UNIVERSITY MEDICAL CENTER
Researchers report first therapy appearing to reverse decline in Parkinson’s
OCTOBER 17, 2015
NEW SCIENTIST
People with Parkinson’s walk again after promising drug trial
NOVEMBER 4, 2014
ALZHEIMER’S NEWS TODAY
Tau protein leads to neuronal death in Alzheimer’s
NOVEMBER 2, 2014
BUSINESS STANDARD
Tau proteins trigger brain cell death in Alzheimer’s
Change the text and add your own content, including any information that is relevant to share. Then customize the font, size and scale to make it your own.
Title 01
Change the text and add your own content, including any information that is relevant to share. Then customize the font, size and scale to make it your own.
Title 02
Change the text and add your own content, including any information that is relevant to share. Then customize the font, size and scale to make it your own.
Title 03
